Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study

References

• O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July–December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–1202.
   PubMed Web of Science ®Google Scholar
• McCall Jones C, Baldwin GT, Compton WM. Recent increases in cocaine-related overdose deaths and the role of opioids. Am J Public Health. 2017;107(3):430–432.
   PubMed Web of Science ®Google Scholar
• Massachusetts Department of Public Health. The Massachusetts opioid epidemic: a data visualization of findings from the Chapter 55 report. 2018. http://www.mass.gov/chapter55/ViewinArticle. Accessed January 17, 2018.
   Google Scholar
• MDPH. Data brief: opioid1-related overdose deaths among Massachusetts residents. 2017. https://www.mass.gov/doc/opioid-related-overdose-deaths-among-ma-residents-august-2017/download. Accessed January 17, 2021.
   Google Scholar
• MDPH. Data brief trends in stimulant-related overdose deaths. 2020. https://www.mass.gov/doc/data-brief-trends-in-stimulant-related-overdose-deaths-february-2020/download.
   Google Scholar
• Aaohn J, Week E, Unit A. Influx of fentanyl-laced counterfeit pills and toxic fentanyl-related compounds further increases risk of fentanyl-related overdose and fatalities. 2016.
   Google Scholar
• DEA Bulletin. DEA-MIA-BUL-039-18: Deadly Contaminated Cocaine Widespread in Florida. DEA Miami Field Division. 2018. https://www.dea.gov/sites/default/files/2018-07/BUL-039-18.pdf.
   Google Scholar
• Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(50–51):1445–1452.
   PubMed Web of Science ®Google Scholar
• DEA. Cocaine/fentanyl combination in Pennsylvania. 2018. https://www.dea.gov/sites/default/files/2018-07/BUL-061-18%20Cocaine%20Fentanyl%20Combination%20in%20Pennsylvania%20–%20UNCLASSIFIED.PDF.
   Google Scholar
• Pichini S, Solimini R, Berretta P, Pacifici R, Busardò FP. Acute intoxications and fatalities from illicit fentanyl and analogues: an update. Ther Drug Monit. 2018;40(1):38–51.
   PubMed Web of Science ®Google Scholar
• McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017;65:283–288.
   PubMed Web of Science ®Google Scholar
• Stein MD, Anderson BJ, Kenney SR, Bailey GL. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder. J Subst Abuse Treat. 2017;77:67–71.
   PubMed Web of Science ®Google Scholar
• Nolan ML, Shamasunder S, Colon-Berezin C, Kunins HV, Paone D. Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention. J Urban Health. 2019;96(1):49–54.
   PubMed Web of Science ®Google Scholar
• Administration DE. National drug threat assessment. Annual drug report 2019. Springfield, Virginia: US Department of Justice, Drug Enforcement Administration; 2019. https://www.dea.gov/sites/default/files/2020-02/DIR-007-20%202019%20National%20Drug%20Threat%20Assessment%20-%20low%20res210.pdf.
   Google Scholar
• Cano M, Oh S, Salas-Wright CP, Vaughn MG. Cocaine use and overdose mortality in the United States: evidence from two national data sources, 2002–2018. Drug Alcohol Depend. 2020;214:108148.
   PubMed Web of Science ®Google Scholar
• Roy É, Richer I, Arruda N, Vandermeerschen J, Bruneau J. Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada. Int J Drug Policy. 2013;24(2):142–149.
   PubMed Web of Science ®Google Scholar
• Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98(1):7–22.
   PubMed Web of Science ®Google Scholar
• Leri F, Stewart J, Tremblay A, Bruneau J. Heroin and cocaine co-use in a group of injection drug users in Montreal. J Psych Neurosci. 2004;29(1):40.
   PubMed Web of Science ®Google Scholar
• Harrell PT, Mancha BE, Petras H, Trenz RC, Latimer WW. Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug Alcohol Depend. 2012;122(3):220–227.
   PubMed Web of Science ®Google Scholar
• Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol. 2008;26(1):1–5.
   Web of Science ®Google Scholar
• Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12(1):54.
   PubMedGoogle Scholar
• Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend. 1995;39(3):231–235.
   PubMed Web of Science ®Google Scholar
• Kedia S, Sell MA, Relyea G. Mono- versus polydrug abuse patterns among publicly funded clients. Subst Abuse Treat Prev Policy. 2007;2(1):33.
   PubMedGoogle Scholar
• Grov C, Kelly BC, Parsons JT. Polydrug use among club-going young adults recruited through time-space sampling. Subst Use Misuse. 2009;44(6):848–864.
   PubMed Web of Science ®Google Scholar
• Lorvick J, Browne EN, Lambdin BH, Comfort M. Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addict Behav. 2018;85:94–99.
   PubMed Web of Science ®Google Scholar
• McKee G, Amlani A, Buxton J. Illicit fentanyl: An emerging threat to people who use drugs in BC. BCMJ. 2015;57(6):235.
   Google Scholar
• Klar S, Brodkin E, Gibson E, et al. Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine—British Columbia, Canada, July 15–18, 2016. Health Promot Chronic Dis Prev Can. 2016;36(9):200–201.
   Web of Science ®Google Scholar
• Armenian P, Whitman JD, Badea A, et al. Notes from the field: unintentional fentanyl overdoses among persons who thought they were snorting cocaine – Fresno, California, January 7, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(31):687–688.
   PubMed Web of Science ®Google Scholar
• Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD. J Psychoactive Drugs. 2018;50(2):167–176.
   PubMed Web of Science ®Google Scholar
• Frank D, Mateu-Gelabert P, Guarino H, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy. 2015;26(1):84–91.
   PubMed Web of Science ®Google Scholar
• Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104(12):2067–2074.
   PubMed Web of Science ®Google Scholar
• Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008;103(6):979–989.
   PubMed Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
   PubMed Web of Science ®Google Scholar
• Best D, Gossop M, Man L-H, Stillwell G, Coomber R, Strang J. Peer overdose resuscitation: multiple intervention strategies and time to response by drug users who witness overdose. Drug Alcohol Rev. 2002;21(3):269–274.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–791.
   PubMed Web of Science ®Google Scholar
• Kestler A, Buxton J, Meckling G, et al. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69(3):340–346.
   PubMed Web of Science ®Google Scholar
• Tobin K, Clyde C, Davey-Rothwell M, Latkin C. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018;59:94–97.
   PubMed Web of Science ®Google Scholar
• You H-S, Ha J, Kang C-Y, et al. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant). Medicine. 2020;99(22):e20033.
   PubMed Web of Science ®Google Scholar
• Ong AR, Lee S, Bonar EE. Understanding disparities in access to naloxone among people who inject drugs in Southeast Michigan using respondent driven sampling. Drug Alcohol Depend. 2020;206:107743.
   PubMed Web of Science ®Google Scholar
• Mass.Gov. Learn more about SUDORS: about the state unintentional drug overdose reporting system. 2021. https://www.mass.gov/service-details/learn-more-about-sudors. Accessed April 16, 2021.
   Google Scholar
• Tongco MDC. Purposive sampling as a tool for informant selection. Ethnobot Res App. 2007;5:147–158.
   Google Scholar
• Bernard HR. Research Methods in Anthropology: Qualitative and Quantitative Approaches. Lanham, MD: Rowman & Littlefield; 2017.
   Google Scholar
• Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems. 1997;44(2):174–199.
   Web of Science ®Google Scholar
• Saldaña J. An introduction to codes and coding. Vol. 3. In: Seaman J, ed. The Coding Manual for Qualitative Researcher. 3rd ed. London, UK, Sage; 2009.
   Google Scholar
• LaRue L, Twillman RK, Dawson E, et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2(4):e192851–e192851.
   Web of Science ®Google Scholar
• Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15(1):46.
   PubMedGoogle Scholar
• Oliva EM, Nevedal A, Lewis ET, et al. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Substance Abuse. 2016;37(1):118–126.
   PubMed Web of Science ®Google Scholar
• Carroll JJ, Marshall BD, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136–145.
   PubMed Web of Science ®Google Scholar
• Moallef S, Nosova E, Milloy M, et al. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134(4):423–431.
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users' perceptions of fentanyl-adulterated and -substituted ‘heroin'. Int J Drug Policy. 2017;46:146–155.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Dayton L, Davey-Rothwell MA, Tobin KE. Fentanyl and drug overdose: perceptions of fentanyl risk, overdose risk behaviors, and opportunities for intervention among people who use opioids in Baltimore, USA. Subst Use Misuse. 2019;54(6):998–1006.
   PubMed Web of Science ®Google Scholar
• Calvo M, MacFarlane J, Zaccaro H, et al. Young people who use drugs engaged in harm reduction programs in New York City: overdose and other risks. Drug Alcohol Depend. 2017;178:106–114.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Harding RW, Kelley R, et al. Post-overdose interventions triggered by calling 911: Centering the perspectives of people who use drugs (PWUDs). PLOS One. 2019;14(10):e0223823.
   PubMed Web of Science ®Google Scholar
• SAMSHA. Five essential steps for first responders. Opioid Overdose Prevention Toolkit. 2018. https://store.samhsa.gov/sites/default/files/d7/priv/five-essential-steps-for-first-responders.pdf. Accessed December 4, 2020.
   Google Scholar
• Stahler GJ, Mennis J, DuCette JP. Residential and outpatient treatment completion for substance use disorders in the US: moderation analysis by demographics and drug of choice. Addict Behav. 2016;58:129–135.
   PubMed Web of Science ®Google Scholar
• DOJ. Community partners unveil campaign designed to raise awareness around the fact that cocaine is likely contaminated with fentanyl and potentially fatal. Clevland, OH: U.S. Attorney’s Office, Northern District of Ohio: Department of Justice; 2019.
   Google Scholar
• Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BD. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3.
   PubMedGoogle Scholar
• Quintana P, Ventura M, Grifell M, et al. The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin. Int J Drug Policy. 2017;40:78–83.
   PubMed Web of Science ®Google Scholar
• Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242–245.
   PubMed Web of Science ®Google Scholar
• Laing MK, Tupper KW, Fairbairn N. Drug checking as a potential strategic overdose response in the fentanyl era. Int J Drug Policy. 2018;62:59–66.
   PubMed Web of Science ®Google Scholar